New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports

Share Article

The Firm is actively filing Risperdal lawsuits in this proceeding on behalf of men and young boys who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication.

Free Case Review
Our Firm continues to represent men in who have filed Risperdal lawsuits in this proceeding, all of whom allegedly suffered male breast growth, or gynecomastia, as a result of the medication.

Nearly 1,100 Risperdal lawsuits (http://www.risperdallawsuit2014.com/ ) have been filed in a consolidated litigation now underway in Pennsylvania state court, Bernstein Liebhard LLP reports.

Documents recently updated in the Philadelphia Court of Common Pleas show 1,079 records included in the state proceeding, all of which involve a drug approved to treat schizophrenia, bipolar disorder and other psychiatric conditions. Many of the cases in this proceeding allege symptoms of Risperdal gynecomastia, a painful and embarrassing condition categorized by male breast growth. Men who have developed breasts after taking this medication allege the need for mastectomies, liposuction and other surgical procedures to remove the excess tissue, which they claim to have been inadequately warned about by Risperdal’s manufacturer, Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals. (In Re: Risperdal Litigation, Case Number 100300296)

“Our Firm continues to represent men in who have filed Risperdal lawsuits in this proceeding, all of whom allegedly suffered male breast growth, or gynecomastia, as a result of the medication” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs including Risperdal. The Firm is currently offering free and confidential case evaluations to individuals who allegedly developed gynecomastia after taking Risperdal.

Risperdal Lawsuits
Risperdal lawsuits filed in the Philadelphia Court of Common Pleas allege similar complications related to the use of the atypical antipsychotic medication, which is approved to treat irritability in children with autism, in addition to adults and adolescents ages 10-to-17 with schizophrenia and bipolar disorder. Research suggests that the treatment is also prescribed to patients with ADHD, although it is not specifically cleared for this use by regulators.*

Among the gynecomastia issues alleged in Risperdal lawsuits, plaintiffs mention breast tenderness, nipple discharge and swelling as resulting from the medication. Claimants accuse Johnson & Johnson and Janssen of failing to properly inform men of the medication’s tendency to produce elevated levels of prolactin, a hormone associated with female breast development and lactation in new mothers.

According to lawsuits, Johnson & Johnson and Janssen have also engaged in off-label promotion of Risperdal, for uses not approved by the U.S. Food and Drug Administration (FDA). In November 2013, the companies agreed to settle charges from the U.S. Department of Justice that partially involved their alleged promotion of Risperdal to elderly patients with dementia and for pediatric uses not cleared by the agency until 2006. The federal government reported that the $2.2 billion settlementwas one of the largest federal case settlements involving healthcare fraud in history.

Men and boys who allegedly developed gynecomastia after their use of Risperdal may be eligible to receive compensation for medical bills, lost wages, pain and suffering and other damages. Learn more about the association between Risperdal and gynecomastia when you visit Bernstein Liebhard LLP’s website. For a free case review, please call 800-511-5092.

*health.usnews.com/health-news/news/articles/2012/08/07/more-kids-taking-antipsychotics-for-adhd-study, U.S. News & World Report, August 7, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
info (at) consumerinjurylawyers (dot) com
http://www.risperdallawsuit2014.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website